NasdaqCM - Nasdaq Real Time Price USD
Aptevo Therapeutics Inc. (APVO)
0.3300
-0.0100
(-2.94%)
As of 12:07:04 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,785
-23,785
-11,730
-21,022
-21,679
Investing Cash Flow
0
0
0
-29
-713
Financing Cash Flow
15,595
15,595
5,998
-2,616
26,161
End Cash Position
8,714
8,714
16,904
22,636
46,303
Capital Expenditure
-147
--
--
-29
-713
Issuance of Capital Stock
10,036
10,036
6,428
6,934
10,233
Repayment of Debt
0
0
-3,467
-12,267
-10,550
Free Cash Flow
-23,785
-23,785
-11,730
-21,051
-22,392
12/31/2021 - 7/20/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GRI GRI Bio, Inc.
1.4400
-3.36%
CERO CERo Therapeutics Holdings, Inc.
0.5835
-1.10%
IBO Impact BioMedical Inc.
0.5493
+0.02%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
PBM Psyence Biomedical Ltd.
4.0100
+2.30%
CDT Conduit Pharmaceuticals Inc.
0.3893
-1.84%
RNAZ TransCode Therapeutics, Inc.
0.3584
+3.23%
ZVSA ZyVersa Therapeutics, Inc.
0.4999
-3.56%
PCSA Processa Pharmaceuticals, Inc.
0.2259
-1.44%
PTIX Protagenic Therapeutics, Inc.
3.2550
-7.26%